Jonathan Savidge
Role: Associate
Site : CDL-Paris
Stream: BioTech
A scientist by training, Jonathan has spent 25 years in the biotech/pharma industry in roles focus on all types of partnerships to progress development of novel therapeutics. He has been CEO of two companies, leading both to significant M&A exits (Syndesi Therapeutics sale to Abbvie and Kynos Therapeutics sale to Dr. Falk Pharm). Jonathan is currently Board Chair at NRG Therapeutics and is an advisor to biotech companies and investors in CNS and pain therapeutic areas.